Uterus Transplants Can Provide a Path to Pregnancy and Parenthood

Why It Matters

The procedure expands reproductive options for a previously untreatable condition and could reshape fertility care, but high costs and limited insurance coverage threaten equitable access.

Key Takeaways

• Baylor performed 44 uterus transplants, achieving 27 live births
• Live birth rate matches IVF success rates, with similar complication profile
• Most donors are living, motivated by helping others experience pregnancy
• Prematurity risk higher than general population but comparable to IVF
• Procedure remains expensive; insurance coverage is currently unavailable

Pulse Analysis

Absolute uterine factor infertility affects roughly one in 500 women, rendering them unable to carry a pregnancy. Uterus transplantation, first successful in Sweden in 2014 and later in the United States, has emerged as a groundbreaking solution, with more than 70 children born globally to date. The field has matured rapidly, shifting from a high‑risk experimental surgery to a reproducible clinical service that aligns closely with established in‑vitro fertilization (IVF) protocols, offering hope to women who previously faced only adoption or surrogacy.

At Baylor University Medical Center, the world’s largest uterus‑transplant program, 44 women underwent the procedure between 2016 and 2026. Of those, 37 achieved successful graft function, 33 proceeded to embryo transfer, and 31 became pregnant, culminating in 27 live births. Neonatal outcomes are encouraging: all infants scored at least 7 on the Apgar scale, and while 11 required NICU care for prematurity, complication rates such as gestational diabetes mirror those seen in standard IVF pregnancies. These results underscore that, once a transplanted uterus is viable, the odds of a healthy birth are comparable to conventional assisted‑reproductive technologies.

Despite clinical success, widespread adoption faces hurdles. Living donors dominate the donor pool, driven by personal motivations to enable motherhood for others, yet the surgery remains resource‑intensive and costly. Insurance providers have yet to recognize uterus transplantation as a reimbursable service, leaving patients to shoulder substantial out‑of‑pocket expenses. Ongoing efforts focus on standardizing protocols, gathering long‑term maternal and child health data, and reducing procedural costs to ensure the technology becomes accessible beyond affluent patients, ultimately integrating into mainstream fertility care.